Prof Maria Dorobantu is Emeritus professor of Cardiology at the University of Medicine and Pharmacy Carol Davila Bucharest, Romania, Corresponding Member of the Romanian Academy She has a special interest in the assessment and treatment of hypertension and acute and chronic heart failure (HF). She has been principal investigator in the phase III RELAX-AHF and RELAX-AHF-2 trials as well as SENIORS and BEAUTIFUL trials. These trials regard the effects of the new agent serelaxin in the patients with acute HF. Between 2008 and 2014 she was a member of CPC of ESC, Group of Hypertension. She was also President of the "Coronary Pathophysiology and Microcirculation" Working Group of the European Society of Cardiology (2016-2018) ,Member of the European Society of Hypertension Board as a Representative of the National Societies of Hypertension (2019-2021) Her current position is President of the Regional Advisory Group Europe (RAG Europe), International Society of Hypertension (ISH) Prof Frank Ruschitzka is head of the HF and Transplantation Clinic at the University Hospital in Zürich, Switzerland. He specialized in internal medicine, nephrology and cardiology at the Universities of Göttingen and Zürich. In 2003, he was awarded the annual Götz-Preis of the Medical Faculty of the University of Zürich for excellence in clinical medicine and research. Heis the President Elect of the HF Association of the ESC.

Professor Ruschitzka's research interests focusses on delineating novel targets and therapies in coronary artery disease and HF. Professor Ponikowski is the Director of the Institute of Heart Diseases at the University Hospital, Wroclaw, Poland. He serves as Member of the Board of the Heart Failure Association of the ESC (2004-); in 2010-2012 he served as the President of the Heart Failure Association, former President of Polish Cardiac Society. He has been involved in the development of several guidelines on the management of cardiovascular diseases edited by the ESC as the member of the ESC C^140000, h-index=138; selected among Highly Cited Researchers by Thomson Reuters 2016-2021.